Irish medical device company Ceroflo has raised €6.4 million in a funding round to advance its disruptive technology to revolutionise the treatment of intracranial atherosclerotic disease (ICAD), a leading cause of stroke. Ceroflo is developing an innovative device for the treatment and prevention of stroke – one of the leading causes of death and disability [&hellip
The post Ceroflo secures €6.4m to develop stroke-treatment device appeared first on TechCentral.ie.
